TheraPsil Unveils MDMA-Assisted Psychotherapy Training Program
The program is aimed at meeting the rising demand for training and treatment in MDMA therapy.
therapsil
Canadian Patients Demand Access to Psilocybin As They Take the Federal Government to Court
Eight Canadian patients one healthcare practitioner demand access to psilocybin as they take the federal government to court
Patients and Medical Professionals to Make First In-Person Appearance in Ottawa This Month
Seeking more compassionate access to psilocybin as an alternative for Canadians suffering from chronic disease, addiction and palliative depression
An Inside Look at the Lawsuit that could “Legalize Psychedelics in Canada”
A lawsuit filed by the non-profit advocacy group TheraPsil is leading the effort to make psilocybin-assisted therapy available to Canadian patients with a doctor’s recommendation
Project Solace: The World’s Largest Medical Psilocybin Access and Data Project
Project Solace uses real-world data to inform development of regulated psilocybin therapy, led by Canadian non-profit TheraPsil
TheraPsil’s Fight to Secure Therapeutic Psilocybin Access for All Canadians
CEO Spencer Hawkswell calls current exemptions for terminally ill under Section 56 of Canada’s Controlled Drugs and Substances Act a “half-assed solution,” and is lobbying for more.
End of content
End of content